KALM-1
Cara Therapeutics, Inc.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87841891 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Algis Anilionis |
| Attorney Docket Number | 0012-0036 |
| Law Office Assigned | N30 |
| Employee Name | ROSEN, AMANDA ROBYN |
Timeline
| 2018-01-31 | Date of First Use |
| 2018-03-20 | Application Filed |
| 2019-01-08 | Abandon |
| 2019-02-05 | Location: TMO LAW OFFICE 121 - EXAMINING ATTORNEY ASSIGNED |
| 2019-02-05 | Status: Dead/Abandoned |
| 2019-02-06 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Cara Therapeutics, Inc. |
| Address | 4 Stamford Plaza, 9th Floor 107 Elm Street Stamford DE 06902 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0421 | Conducting of clinical trials of pharmaceutical preparations |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2018-03-23 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-03-29 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2018-06-29 | 3 DOCK D:Assigned to Examiner |
| PRIORITY ACTION WRITTEN | 2018-07-06 | 4 CPRA R:Renewal |
| PRIORITY ACTION E-MAILED | 2018-07-06 | 5 GPRA F:First Action |
| NOTIFICATION OF PRIORITY ACTION E-MAILED | 2018-07-06 | 6 GPRN O:Outgoing Correspondence |
| ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | 2019-02-05 | 7 ABN2 O:Outgoing Correspondence |
| ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | 2019-02-06 | 8 MAB2 E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 